You are here: Home » Current Affairs » News

LIVE: Delhi, Mumbai report sharp uptick in daily Covid cases

Delhi sees 50% jump in cases from yesterday, while Mumbai reports nearly 70% rise

Today News | Coronavirus | Omicron

BS Web Team  | New Delhi 


Latest Live News: India has approved Merck's Covid-19 pill and two more vaccines for emergency use as the world's second most populous country braces for a possible spike in cases due to the rapidly spreading variant.

Molnupiravir will be manufactured in India by 13 companies for restricted use under emergency situation for treatment of adult patients with Covid-19, said Health Minister Mansukh Mandaviya on Tuesday.

Merck's anti-viral pill molnupiravir was authorised by the United States last week for certain high-risk adult patients and has been shown to reduce hospitalisations and deaths by around 30 per cent in a clinical trial. 

Two other Covid-19 vaccines, Serum Institute of India's version of Novavax Inc's shot, Covovax, and homegrown drugmaker Biological E's Corbevax were also granted emergency use approval, Mandaviya said on Twitter.

New restrictions with a "yellow alert" will take effect in Delhi amid a rise in Covid cases, Chief Minister Arvind Kejriwal today said, adding that a "detailed order" will be shared soon.


Auto Refresh

First Published: Tue, December 28 2021. 08:03 IST